Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix

[1]  J. Roa,et al.  Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix , 2012, Clinical Epigenetics.

[2]  Dehua Ma,et al.  DNA methylation changes in cervical cancers. , 2012, Methods in molecular biology.

[3]  L. Kristensen,et al.  Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP. , 2011, Lung cancer.

[4]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[5]  M. Mokni,et al.  p16INK4A overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women. , 2010, Pathology, research and practice.

[6]  L. Carreto,et al.  MicroRNA Expression Variability in Human Cervical Tissues , 2010, PloS one.

[7]  S. Galande,et al.  p300-mediated Acetylation of Histone H3 Lysine 56 Functions in DNA Damage Response in Mammals , 2010, The Journal of Biological Chemistry.

[8]  Hongbing Shen,et al.  Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women. , 2010, Gynecologic oncology.

[9]  H. Kim,et al.  HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? , 2010, Journal of radiation research.

[10]  M. Esteller,et al.  Viral epigenomes in human tumorigenesis , 2010, Oncogene.

[11]  M. Widschwendter,et al.  Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers. , 2010, Epigenomics.

[12]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[13]  Liang-Hu Qu,et al.  MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. , 2009, Biochemical and biophysical research communications.

[14]  L. Banks,et al.  Human papillomavirus infection, cancer & therapy. , 2009, The Indian journal of medical research.

[15]  B. Das,et al.  Infection of human papillomaviruses in cancers of different human organ sites. , 2009, The Indian journal of medical research.

[16]  D. Iliopoulos,et al.  Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression. , 2009, Oncology reports.

[17]  Cheng-Chang Chang,et al.  Methylation analysis of SFRP genes family in cervical adenocarcinoma , 2009, Journal of Cancer Research and Clinical Oncology.

[18]  J. Kónya,et al.  Epigenetic alterations in cervical carcinogenesis. , 2009, Seminars in cancer biology.

[19]  Ricky W. Johnstone,et al.  Epigenetics in cancer: Targeting chromatin modifications , 2009, Molecular Cancer Therapeutics.

[20]  P. Martin-Hirsch,et al.  p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. , 2009, Cancer treatment reviews.

[21]  Huey-Kang Sytwu,et al.  SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. , 2009, Gynecologic oncology.

[22]  T. Kiyono,et al.  Molecular mechanisms of cervical carcinogenesis by high‐risk human papillomaviruses: novel functions of E6 and E7 oncoproteins , 2009, Reviews in medical virology.

[23]  S. JuanCarlosRoa,et al.  Detección y tipificación de virus papiloma humano en adenocarcinoma de cuello uterino mediante reverse line blot, Región de La Araucanía, Chile , 2009 .

[24]  K. Münger,et al.  The human papillomavirus E7 oncoprotein. , 2009, Virology.

[25]  Cheng-Chang Chang,et al.  Promoter methylation of SFRPs gene family in cervical cancer. , 2009, Gynecologic oncology.

[26]  Priscilla Brebi M,et al.  [Detection and genotyping of human papillomavirus in biopsies of uterine cervical adenocarcinoma]. , 2009, Revista medica de Chile.

[27]  N. Nour.  Cervical cancer: a preventable death. , 2009, Reviews in obstetrics & gynecology.

[28]  Joakim Dillner,et al.  Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV‐associated cancers , 2008, International journal of cancer.

[29]  S. Hwang,et al.  Altered MicroRNA Expression in Cervical Carcinomas , 2008, Clinical Cancer Research.

[30]  W. Grizzle,et al.  Mandatory fortification with folic acid in the United States is associated with increased expression of DNA methyltransferase-1 in the cervix. , 2008, Nutrition.

[31]  C. Readhead,et al.  Analysis of the genetic interactions between Cyclin A1, Atm and p53 during spermatogenesis. , 2007, Asian journal of andrology.

[32]  T. Kiyono,et al.  Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteins , 2007, Cancer science.

[33]  K. Shroyer,et al.  Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma , 2007, Cancer.

[34]  C. Woodman,et al.  The natural history of cervical HPV infection: unresolved issues , 2007, Nature Reviews Cancer.

[35]  H. Boezen,et al.  Assessment of gene promoter hypermethylation for detection of cervical neoplasia , 2006, International journal of cancer.

[36]  Zhi-Ming Zheng,et al.  Papillomavirus genome structure, expression, and post-transcriptional regulation. , 2006, Frontiers in bioscience : a journal and virtual library.

[37]  Xavier Castellsagué,et al.  Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.

[38]  N. Park,et al.  Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma , 2006, International journal of cancer.

[39]  S. Arya.  Evaluation of OPV and polio eradication. , 2006, Vaccine.

[40]  S. Niruthisard,et al.  Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer , 2006, BMC Cancer.

[41]  M. Lizano,et al.  Epigenetics of cervical cancer. An overview and therapeutic perspectives , 2005, Molecular Cancer.

[42]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[43]  M. Salto‐Tellez,et al.  Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1 , 2005, Cell Death and Differentiation.

[44]  J. Doorbar.  The papillomavirus life cycle. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[45]  L. Harris,et al.  Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. , 2005, Molecular cancer therapeutics.

[46]  E. Lee,et al.  The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions , 2005, Journal of Cancer Research and Clinical Oncology.

[47]  Conrad A. Nieduszynski,et al.  The Cyclin A1-CDK2 Complex Regulates DNA Double-Strand Break Repair , 2004, Molecular and Cellular Biology.

[48]  S. Nomoto,et al.  Inverse Correlation between Cyclin A1 Hypermethylation and p53 Mutation in Head and Neck Cancer Identified by Reversal of Epigenetic Silencing , 2004, Cancer Research.

[49]  E. Furth,et al.  DNA methylation profiling of cervical squamous intraepithelial lesions using liquid‐based cytology specimens , 2004, Cancer.

[50]  Meenakshi Singh,et al.  Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. , 2004, Human pathology.

[51]  H. Ngan,et al.  p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after Radiotherapy , 2004, Clinical Cancer Research.

[52]  S. Toyooka,et al.  Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types , 2004, International journal of cancer.

[53]  A. Semczuk,et al.  Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis. , 2004, Cancer letters.

[54]  L. Mariani,et al.  DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. , 2003, Oncology reports.

[55]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[56]  Eileen M. Burd,et al.  Human Papillomavirus and Cervical Cancer , 1988, The Lancet.

[57]  J. Benítez,et al.  Frequent inactivation of the p73 gene by abnormal methylation or LOH in non‐Hodgkin's lymphomas , 2002, International journal of cancer.

[58]  Karl Münger,et al.  Human papillomavirus immortalization and transformation functions. , 2002, Virus research.

[59]  J. Issa,et al.  DNA methylation patterns at relapse in adult acute lymphocytic leukemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[60]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[61]  N. Muñoz,et al.  Human papillomavirus infection and invasive cervical cancer in Paraguay , 2000, International journal of cancer.

[62]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[63]  K. Wakasa,et al.  Alteration of p16 and p15 genes in human uterine tumours , 1999, British Journal of Cancer.

[64]  Xinbin Chen,et al.  The potential tumor suppressor p73 differentially regulates cellular p53 target genes. , 1998, Cancer research.

[65]  R. Nusse,et al.  Wnt signaling: a common theme in animal development. , 1997, Genes & development.

[66]  A. Giuliano,et al.  Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma , 1994, Cancer.